Undisclosed Global Investment Firm

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Mar 31, 2021	Entrada Therapeutics	$116.0M Series B	Wellington Management	Kush Parmar, Agent Capital, CureDuchenne Ventures, Goldman Sachs, Greenspring Associates, MPM Capital, MRL Ventures Fund, Point72, Qatar Investment Authority, Redmile Group, Roche, TCGX

Total Raised

N/A

Valuation

N/A